NIRMAN AGRI GENETICS
|
|
BOM :      NSE : NIRMAN     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Mar 10,2025 |
Price(EOD): ₹ 223.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Agriculture |
MCap: ₹ 178.96 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
NIRMAN AGRI GENETICS | -3.6% | -36.5% | 9% |
BOMBAY BURMAH TRADING CORPORATION | -2.9% | -20.1% | 2% |
KAVERI SEED COMPANY | -2% | 8.8% | 57.1% |
VENKYS (INDIA) | -3.1% | -9.8% | -8.6% |
BOMBAY SUPER HYBRID SEEDS | -5.1% | -19.2% | -40.2% |
INDO US BIOTECH | -5.6% | -22.4% | -26.2% |
MANGALAM GLOBAL ENTERPRISE | -6.4% | 4.5% | NA |
HARRISONS MALAYALAM | -3.6% | -26.5% | 3.7% |
TIERRA AGROTECH | 1.7% | -22% | -44.1% |
FUNDAMENTAL ANALYSIS OF NIRMAN AGRI GENETICS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF NIRMAN AGRI GENETICS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
8.33
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 21.52 Cr
[Latest Qtr - Dec2024 - Standalone Results ] 4.8
P/B Calculated based on Book Value of Rs 37.34 Cr
[Latest Year - Mar2024 - Standalone Results ] 0.92
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-47% -77% -89% |
SHARE PRICE MOMENTUM OF NIRMAN AGRI GENETICS
NIRMAN AGRI GENETICS vs SENSEX
DEBT OF NIRMAN AGRI GENETICS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.02 0.04 0.54 0.2 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF NIRMAN AGRI GENETICS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Sep2024 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF NIRMAN AGRI GENETICS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-1.64% 6.95% 2.99% 4.88% |
223.27% 124.77% 117.29% 114.06% |
QtrlyTrend |
6 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
NIRMAN AGRI GENETICS related INDICES
You may also like the below Video Courses
FAQ about NIRMAN AGRI GENETICS
Is NIRMAN AGRI GENETICS good for long term investment?
As on Mar 10,2025, the Fundamentals of NIRMAN AGRI GENETICS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NIRMAN AGRI GENETICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is NIRMAN AGRI GENETICS UnderValued or OverValued?
As on Mar 10,2025, NIRMAN AGRI GENETICS is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of NIRMAN AGRI GENETICS ?
As on Mar 10,2025, the Intrinsic Value of NIRMAN AGRI GENETICS is Rs. 954.12 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 419.55
Fair Value [Median EV / Sales Model] : Rs. 954.12
Fair Value [Median Price / Sales Model] : Rs. 1,963.56
Estimated Median Fair Value of NIRMAN AGRI GENETICS : Rs. 954.12
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.